<DOC>
	<DOCNO>NCT02836743</DOCNO>
	<brief_summary>To evaluate effect slow-release melatonin ( Circadin ) REM sleep behavior disorder .</brief_summary>
	<brief_title>Effect Slow-release Melatonin ( CircadinÂ® ) Therapy Idiopathic RBD : Pilot Study</brief_title>
	<detailed_description>Investigators plan administer low ( 2mg ) high ( 6mg ) dose slow-release melatonin placebo 4 week evaluate Clinical Global Impression scale , RBD questionnaire , PSQI , Epworth sleepiness scale , quality life questionnaire ( SF-36v2 ) treatment along possible side effect drug compliance .</detailed_description>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>REM Sleep Behavior Disorder</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>REM sleep behavior disorder accord ICSD3 criterion No cognitive deficit symptom Parkinsonism Those write consent . take medication ( ex . clonazepam ) REM sleep behavior disorder degenerative neurologic disorder ( ex . Parkinson 's disease , Multiple System Atrophy , Lewybody dementia , etc . ) take medication affect REM sleep behavior disorder ( antidepressant : SSRI , TCA , MAOinhibitor ) unable answer questionnaire hypersensitive reaction medication Pregnant woman breastfeed diagnosed parasomnia disorder severe medical disorder ( severe liver failure , respiratory failure , heart failure , malignant tumor , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>REM sleep behavior disorder</keyword>
	<keyword>Melatonin</keyword>
</DOC>